BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 10, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 14, 1999
View Archived Issues
In vitro and in vivo testing shows chondrogenic effects for TAK-778
Read More
Company Profile: IntroGene
Read More
Micro Therapeutics treats first aneurysm patient with ONYX
Read More
CytRx completes patient enrollment in phase III pivotal study of Flocor
Read More
Vion to commence phase I trial of VNP-20009
Read More
Candidate stroke treatment advances to phase I at Shire
Read More
Disappointing results reported from phase III lisofylline trial
Read More
NuChem's anticancer drug candidates to be featured at upcoming oncology meeting
Read More
Chiron to supply meningitis C vaccine to U.K.'s NHS
Read More
Cabergoline: new use in restless legs syndrome
Read More
Celgene discovers new class of compounds inhibiting inflammatory cytokine production
Read More
New PKC inhibitors in development at AstraZeneca
Read More
Metabotropic glutamate receptor ligands from Pfizer useful for neurological, psychiatric disorders
Read More
Modulators of PTPases and their use described by Novo Nordisk
Read More
Merck's new fibrinogen receptor antagonists disclosed in recent patent
Read More
Risedronate featured in JAMA; Sweden issues first approval for osteoporosis
Read More
New bronchial therapeutics in the Byk Gulden pipeline
Read More
A total of six dementia-related proteins accepted by Bayer from Myriad Genetics
Read More
Hemosol reacquires all rights to oxygen therapeutic
Read More
Funds from NIST to be used to advance Reprogenesis's lead product into clinic
Read More
Marked and progressive bone anabolic effects found for SDZ-PTH-893 in OVX rats
Read More
Ariflo is a promising new treatment for COPD
Read More
Further SAR studies on phenyloxazolidinones reported at ICAAC by Pharmacia & Upjohn
Read More
Clinical pharmacokinetic and safety data reported for anti-HIV calanolide compound
Read More
Treatment with Tamiflu reduces secondary complications of influenza and need for antibiotics
Read More
L-084: a new oral carbapenem with good safety, favorable pharmacokinetics in humans
Read More
Urodilatin: a novel treatment approach for patients with moderate to severe asthma
Read More
MS-8209 found to be most potent known antiscrapie agent; results presented at ICAAC
Read More
